Takeda’s seizure drug fails to meet main goal in late-stage studies, ET HealthWorld
London: Japanese drugmaker Takeda said on Monday its experimental drug being tested for two epileptic disorders failed to reduce frequency of seizures in patients across late-stage studies. The drug, soticlestat,…